TOP TEN perturbations for 1490_at (Homo sapiens)
Organism: Homo sapiens
Gene: 1490_at
Selected probe(set): 214058_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 1490_at (214058_at) across 6537 perturbations tested by GENEVESTIGATOR:
IFN-g study 11 / normal monocyte sample
Relative Expression (log2-ratio):-4.482089Number of Samples:7 / 7
| Experimental | IFN-g study 11 |
| Monocyte samples isolated from donors and stimulated in vitro by 100 ng/ml IFNγ in whole blood for 1.5 hour. Following stimulation, monocyte were depleted from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. | |
| Control | normal monocyte sample |
| Monocyte samples isolated from healthy subjects. Peripheral blood monocytes were isolated immediately after drawing blood by depletion from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. |
IFN-g study 11 / unstimulated monocyte sample
Relative Expression (log2-ratio):-4.21531Number of Samples:7 / 11
| Experimental | IFN-g study 11 |
| Monocyte samples isolated from donors and stimulated in vitro by 100 ng/ml IFNγ in whole blood for 1.5 hour. Following stimulation, monocyte were depleted from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. | |
| Control | unstimulated monocyte sample |
| Monocyte samples isolated from healthy donors and incubated in whole blood for 1.5 hour without any stimulation. Following incubation, monocyte were depleted from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. |
stem cell differentiation study 59 (iDRG; 15d) / stem cell differentiation study 59 (8d)
Relative Expression (log2-ratio):-4.1318016Number of Samples:4 / 4
| Experimental | stem cell differentiation study 59 (iDRG; 15d) |
| Immature dorsal root ganglia neurons (iDRGs) obtained by differentiation of WA09 embryonic stem cells. WA09 cells were differentiated for 8 days and subsequently cryopreserved. After thawing, cells were further differentiated for 7 days. Further details are described in the paper. | |
| Control | stem cell differentiation study 59 (8d) |
| WA09 embryonic stem cell samples differentiated for 8 days. Further details are described in the paper. |
IFNa-2a study 1 / normal monocyte sample
Relative Expression (log2-ratio):-3.957841Number of Samples:7 / 7
| Experimental | IFNa-2a study 1 |
| Monocyte samples isolated from healthy donors and stimulated in vitro by 100 ng/ml IFNα2a in whole blood for 1.5 hour. Following stimulation, monocyte were depleted from granulocytes using CD15 MACS beads, and they were sorted from remaining peripheral blood leukocyte by CD14 labeling. | |
| Control | normal monocyte sample |
| Monocyte samples isolated from healthy subjects. Peripheral blood monocytes were isolated immediately after drawing blood by depletion from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. |
rheumatoid arthritis study 31 / IFN-g study 11
Relative Expression (log2-ratio):3.8167248Number of Samples:4 / 7
| Experimental | rheumatoid arthritis study 31 |
| Monocyte samples isolated from patients with rheumatoid arthritis (RA). Monocyte from whole blood were depleted from granulocytes by CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. Patients fulfilled the revised American College of Rheumatology criteria (ACR) for RA. | |
| Control | IFN-g study 11 |
| Monocyte samples isolated from donors and stimulated in vitro by 100 ng/ml IFNγ in whole blood for 1.5 hour. Following stimulation, monocyte were depleted from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. |
IFNa-2a study 1 / unstimulated monocyte sample
Relative Expression (log2-ratio):-3.691062Number of Samples:7 / 11
| Experimental | IFNa-2a study 1 |
| Monocyte samples isolated from healthy donors and stimulated in vitro by 100 ng/ml IFNα2a in whole blood for 1.5 hour. Following stimulation, monocyte were depleted from granulocytes using CD15 MACS beads, and they were sorted from remaining peripheral blood leukocyte by CD14 labeling. | |
| Control | unstimulated monocyte sample |
| Monocyte samples isolated from healthy donors and incubated in whole blood for 1.5 hour without any stimulation. Following incubation, monocyte were depleted from granulocytes using CD15 MACS beads, and afterwards they were sorted from remaining peripheral blood leukocyte by CD14 labeling. |
stem cell differentiation study 59 (iDRG; 12d) / stem cell differentiation study 59 (8d)
Relative Expression (log2-ratio):-3.5178785Number of Samples:4 / 4
| Experimental | stem cell differentiation study 59 (iDRG; 12d) |
| Immature dorsal root ganglia neurons (iDRGs) obtained by differentiation of WA09 embryonic stem cells. WA09 cells were differentiated for 8 days and subsequently cryopreserved. After thawing, cells were further differentiated for 4 days. Further details are described in the paper. | |
| Control | stem cell differentiation study 59 (8d) |
| WA09 embryonic stem cell samples differentiated for 8 days. Further details are described in the paper. |
pediatric meningococcal sepsis study 3 (early) / normal PBMC (CD14+) sample
Relative Expression (log2-ratio):-3.4677448Number of Samples:2 / 3
| Experimental | pediatric meningococcal sepsis study 3 (early) |
| CD14 positive cell fraction (PBMC CD 14+) isolated from peripheral blood mononuclear cells. Peripheral blood mononuclear cells were derived from whole blood drawn from children with meningococcal sepsis at time of admission to the pediatric intensive care unit (0h). | |
| Control | normal PBMC (CD14+) sample |
| CD14 positive cell fraction (PBMC CD 14+) isolated from peripheral blood mononuclear cells. Peripheral blood mononuclear cells were derived from whole blood drawn from matched control subjects. |
monocyte activation study 1 (TLR/1L; 24h) / monocyte activation study 1 (TLR/1L; 6h)
Relative Expression (log2-ratio):3.4480324Number of Samples:5 / 5
| Experimental | monocyte activation study 1 (TLR/1L; 24h) |
| Monocytes were isolated from five healthy donors, cultured in RPMI with 10% vitamin D–sufficient (100 nM) human serum and activated for 24 hours with 1 ug/ml mycobacterial 19-kDa triacylated lipopeptide (TLR2/1 ligand, TLR2/1L). This type of activation is via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1). | |
| Control | monocyte activation study 1 (TLR/1L; 6h) |
| Monocytes were isolated from five healthy donors, cultured in RPMI with 10% vitamin D–sufficient (100 nM) human serum and activated for 6 hours with 1 ug/ml mycobacterial 19-kDa triacylated lipopeptide (TLR2/1 ligand, TLR2/1L). This type of activation is via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1). |
diclofenac study 6 (55uM) / vehicle (PBS) treated HepG2 sample
Relative Expression (log2-ratio):3.4407892Number of Samples:3 / 12
| Experimental | diclofenac study 6 (55uM) |
| HepG2 cells treated with compound: diclofenac (55uM; CAS no.:15307-86-5) for 24 hours. Diclofenac is hepatotoxic and may cause necrosis. HepG2 cells were treated with the IC20 concentration measured after 24 hours. ATC code:, , | |
| Control | vehicle (PBS) treated HepG2 sample |
| HepG2 cells treated with PBS (0.5% v/v) as solvent control for 24 hours. |